The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed-Reference-Cited by-同舟云学术

The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed

Published:2023-05-25 Issue:7 Volume:46 Page:619-623
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Younus Manal M.^ORCID,Alkhakany Mayada^ORCID,Bahri Priya^ORCID,Caro Angela^ORCID,Rostom Hadir^ORCID,Ndagije Helen Byomire^ORCID,Elhawary Mohamed A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

https://link.springer.com/content/pdf/10.1007/s40264-023-01313-4.pdf

Reference27 articles.

1. Carman KL, et al. Patient and family engagement: a framework for understanding the elements and developing interventions and policies. Health Aff. 2013;32(2):223–31. https://doi.org/10.1377/hlthaff.2012.1133.

2. The ISoP Special Interest Group on Medicinal Product Risk Communication (ISoP CommSIG). https://isoponline.org/special-interest-groups/risk-communication-group/. Accessed 18 Sept 2022.

3. Vat LE, et al. Evaluating the ‘return on patient engagement initiatives’ in medicines research and development: a literature review. Health Expect. 2020;23(1):5–18. https://doi.org/10.1111/hex.12951.

4. Domecq JP, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014. https://doi.org/10.1186/1472-6963-14-89.

5. Sant’Anna A, Vilhelmsson A, Wolf A. Nudging healthcare professionals in clinical settings: a scoping review of the literature. BMC Health Serv Res. 2021. https://doi.org/10.1186/s12913-021-06496-z.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How could employing the patient perspective transform pharmacovigilance?;Expert Opinion on Drug Safety;2024-07-02

2. A Framework for Promoting Safety Monitoring of Herbal Medicines: The International Society of Pharmacovigilance Special Interest Group on Herbal and Traditional Medicines;Drug Safety;2024-05-08

3. Patient and Public Involvement in Pharmacovigilance;Principles and Practice of Pharmacovigilance and Drug Safety;2024

4. Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making;Drug Safety;2023-12-11

5. The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs);Drug Safety;2023-10-24